Literature DB >> 6405272

Economic evaluation of neonatal intensive care of very-low-birth-weight infants.

M H Boyle, G W Torrance, J C Sinclair, S P Horwood.   

Abstract

We evaluated the economic aspects of neonatal intensive care of very-low-birth-weight infants, using outcomes and costs of care before and after the introduction of a regional neonatal-intensive-care program. Neonatal intensive care increased both survival rates and costs. For newborns weighing 1000 to 1499 g, the cost (in 1978 Canadian dollars) was $59,500 per additional survivor, $2,900 per life-year gained, and $3,200 per quality-adjusted life-year gained; intensive care resulted in a net economic gain when figures were undiscounted but a net economic loss when future costs, effects, and earnings were discounted at 5 per cent per annum. For infants weighing 500 to 999 g, the corresponding costs were $102,500 per additional survivor, $9,300 per life-year gained, and $22,400 per quality-adjusted life-year gained; intensive care resulted in a net economic loss. By every measure of economic evaluation, the impact of neonatal intensive care was more favorable among infants weighing 1000 to 1499 g than among those weighing 500 to 999 g. A judgment concerning the relative economic value of neonatal intensive care of very-low-birth-weight infants requires a comparison with other health programs.

Entities:  

Mesh:

Year:  1983        PMID: 6405272     DOI: 10.1056/NEJM198306023082206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  71 in total

1.  Trends and variations in perinatal mortality and low birthweight: the contribution of socio-economic factors.

Authors:  I N Luginaah; K S Lee; T J Abernathy; D Sheehan; G Webster
Journal:  Can J Public Health       Date:  1999 Nov-Dec

Review 2.  Fundamentals of clinical economics in health interventions.

Authors:  S Awasthi
Journal:  Indian J Pediatr       Date:  2000-05       Impact factor: 1.967

3.  Is there such a thing as a life not worth living?

Authors:  B Farsides; R J Dunlop
Journal:  BMJ       Date:  2001-06-16

4.  Linking the health utilities index to National Medical Expenditure Survey data.

Authors:  J A Rizzo; S Pashko; R Friedkin; J Mullahy; J L Sindelar
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

5.  The long-term prognosis of pre-term infants: conceptual, methodological, and ethical issues.

Authors:  Linda S Siegel
Journal:  Hum Nat       Date:  1994

Review 6.  Information barriers to the implementation of economic evaluations in Japan.

Authors:  Shuzo Nishimura; George W Torrance; Naoki Ikegami; Shunichi Fukuhara; Michael Drummond; François Schubert
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Dangerous economics: resource allocation in the NICU.

Authors:  J A Zupancic
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

8.  Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?

Authors:  W K Fant
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

9.  The reliability of cost-utility estimates in cost-per-QALY league tables .

Authors:  S Petrou; M Malek; P G Davey
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

10.  Prenatal care and pregnancy outcomes during the recession: the Washington State experience.

Authors:  E S Fisher; J P LoGerfo; J R Daling
Journal:  Am J Public Health       Date:  1985-08       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.